Footnotes

Draft National Health (Pharmaceutical Benefits – Charges) Regulations 2008

[1]        Senate Community Affairs Committee, National Health Amendment (Pharmaceutical and Other Benefits – Cost Recovery) Bill 2008, p.3.

[2]        Senate Community Affairs Committee, National Health Amendment (Pharmaceutical and Other Benefits – Cost Recovery) Bill 2008, p.19.

[3]        Submission 5, Attachments B and C (DoHA).

[4]        Committee Hansard, 22.09.08, p.CA1 (Ms D Daniell, PCA).

[5]        Committee Hansard, 22.09.08, p.CA16 (Mr W Delaat, Medicines Australia).

[6]        Committee Hansard, 22.09.08, p.CA16 (Mr W Delaat, Medicines Australia).

[7]        Committee Hansard, 22.09.08, p.CA7 (Mr T Vines).

[8]        Committee Hansard, 25.09.08, p.CA10 (Mr D Learmonth, DoHA).

[9]        Committee Hansard, 22.09.08, p.CA15 (Mr W Delaat, Medicines Australia).

[10]      Committee Hansard, 25.09.08, p.CA2 (Prof S Carney, Royal Australasian College of Physicians).

[11]      Committee Hansard, 22.09.08, p.CA8 (Mr T Vines).

[12]      Committee Hansard, 22.09.08, p.CA8 (Mr T Vines).

[13]      Committee Hansard, 25.09.08, p.CA18 (Mr D Learmonth, DoHA).

[14]      Submission 6, p.1 (GMiA).

[15]      Explanatory Statement, p.6.

[16]      Committee Hansard, 22.09.08, p.CA2 (Mr B Shaw, PCA).

[17]      Committee Hansard, 22.09.08, p.CA1 (Ms D Daniell, PCA).

[18]      Committee Hansard, 25.09.08, p.CA14 (Mr W Delaat, Medicines Australia).

[19]      Committee Hansard, 25.09.08, p.CA20 (Mr W Delaat, Medicines Australia).

[20]      Submission 8, p.4 (Medicines Australia).

[21]      Submission 2, p.1 (PCA).

[22]      Committee Hansard, 25.09.08, p.CA16 (Mr D Learmonth, DoHA).

[23]      Committee Hansard, 25.09.08, p.CA15 (Mr W Delaat, Medicines Australia); see also Submission 8, p.4 (Medicines Australia).

[24]      Submission 8, p.4 (Medicines Australia).

[25]      Submission 7, p.3 (AMA).

[26]      Committee Hansard, 25.09.08, p.CA16 (Mr D Learmonth, DoHA).

[27]      Committee Hansard, 25.09.08, p.CA8 (Mr D Learmonth, DoHA); see also p.CA17.

[28]      Submission 7, p.3 (AMA).

[29]      Committee Hansard, 22.09.08, p.CA11 (Mr F Sullivan, AMA); see also Submission 7, p.3 (AMA).